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I ~  Excimer Laser in the Treatment of Angioplasly 
Instant RsstenoMs: An Intravascuiar Ultrasound 
Study 
Roxana Mehren, Gary S. Mintz, Jeffrey J. Popma, Augusto D. Pioherd, 
Lowell F. Sailer, Kenneth M. Kent, S. Chlu Wong, Martin B. Leon. 
Washington Haspitat Center, Washington, DC 
Treatment of instant restenosls using PTCA extrudes some neolntimal tissue 
out of the stsnt and redistributes the residual tissue over a greater slant 
cl,-cumference (post-repeat PTCA). Alternatively, we used excimer laser an- 
gioplasty (ELCA) to ablate neointimal tissue prior to repeat PTCA (especially 
in longer or more severe restenotic lesions) and assessed the results using 
intravaScular ultrasound {IVUS: measurement of stenL lumen, and intimal 
hyperplasia areas (mm~)} before ELCA and after adjunctive PTCA. 
Pre-intervonrion Post ELCA + PTCA p 
Slant area 7.2 ± 2.1 8.4 ± 2.3 < 0.0001 
Lumen area 1.6 :l: 0.8 6.4 ± 1.7 < 0.0001 
Inttma! hyperplasia area 53±2.3 2.0~1.3 < 0.0001 
The 30 restenntic stents treated with ELCA + PTCA were then compared 
to 45 restenotic slants treated with PTCA alone. Despite longer lengths of 
neointima[ tissue within the stents (17.8 4- 9.9 vs 13.1:1:10,0 ram, p = 
0.0662), the combination of ELCA + PTCA resulted in (1) a greater lumen 
gain (3.9 .;- 2.2 vs 2.5 4- 3.5 mm 2, p = 0.0640), (2) a greater decrease in 
intimal hyperplasia distributed within the stent (2.2 4- 2.0 vs 0.6 • 3.t mm 2, 
p = 0.0249), and (3) less residual intimal hyperplssia within the stent (2.2 :t: 
1.4 vs 3.2 4- 2.4 tarrY, p = 0.0431). We conclude: ELCA offerS an attractive 
alternative to PTCA for the treatment of instant restenosis, particularly severe 
diffuse instsnt restenosis with a large burden of neointimal tissue. Rather 
than extruding tissue out of the slant or redistributing tissue over a greater 
stent alrcumference, ELCA appearS to ablate (is., remove) neointimal tissue 
facilitating adjunctive PTCA. 
i101 - 106, I A Serial Volumetric Intravascular Ultrasound 
"1 
1 
' Analysis o! Instant  Restenosis 
Gaston R. Dussalilant, Gary S. Mintz, Augusto D. Pichard, Kenneth 
M. Kent, Lowell R Seller, Jeffrey J. Popma, Paul Mackel, Caret Welsh, S. 
Chlu Wong, Carolyn Ewels, Ann Greenberg, Theresa Bucher, Martin 
B. Leon. Washington Hospital Center, Washington DC 
We pedormed serial volumetric intrevascular ultrasound analysis {IVUS post- 
intervention and at follow-up (F/U) @ 3.9 4-1.8 months) in 32 native coronary 
and 9 vein grail lesions treated with 52 Palmaz-Schatz slants and adjunctive 
high-pressure PTCA (15~5 4- 3.7 arm). Motorized transducer pullback @ 0.5 
mm/sec through a stationary imaging sheath permitted measutements of 
stent and lumen areas in 2 mm axial increments and calculation of slant, 
lumen, and neointimal hyperplasia (slant-lumen) volumes (in mm ~) using 
SImpsan's rule. Overall, stent volume was 131 4- 72 romp post-PTCA and 
did not change at F/U, Lumen volume decreased from 129 -~ 71 rnm s post- 
PTCA to 88 4- 67 mm ~ (p < 0.0001) at FJU, due to the accumulation of 43 
26 mn~ of neointimal tissue/slant. A comparison of 24 restenotic and 17 
nenrestenotlo lesions showed: 
No restenos=s ~es',enos~e p 
POst-PTCA slant volume 169 :t: 80 103 ~: 52 0,0029 
POSt.PTCA lumen volume 107 - 80 102 ~ 50 0.0027 
F/U slant volume 169 ± 80 104 ~ 52 0.0028 
F/U lumen volume 134 ± 69 54 :I: 40 < 0,0001 
& slant volume 0 ± 3 0 ~ 2 NS 
Intima! hyperplasla volume 34 :t: 22 50 .~ 27 0,066 
We conclude: Sedal volumetric iVUS analysis shows that intimal hyper- 
plasia causes In-stent restenosis. Regardless of lesion location (native vs 
SVG), stsnt compression does not occur as there is no chronic decrease in 
slant volume even in restenotl¢ slants. 
• Oetenninatlon of the Mechanisms Responsible 
for stent Rsstenosls: A Quantitative 
Angiogrephlc Study 
Gl!berto Nunes, Fausto Feros, Galo Maldonado, Luiz Tanajura, Luiz Mattos, 
Ibraim Pinto, Aurae Cheves, Marinella Centemero, Amanda Souse, J. 
Eduardo Sousa. Institute Dante Pazzanese of Cardiology, S~o Paulo, Brazil 
The purpose of this study was to determine the relative contribution of 
three distinct mechanisms [elastic recoil (REC), slant compr~ssicn (SC), 
and Intimal hyperplasia (IH)] in the late lumen loss that follows co~nary 
slant implantation. Eighty pts who underwent elective or emergency Palmaz- 
Schatz stent placement and had a late angiogram performed were evaluated. 
Repeat catheterization was performed due to completion of the follow-up 
period (6 month) or evidence of recurrent ischemla. The paired anglogrems 
(initial and follow-up} were analyzed by quantitative coronary angiography 
using an automated edge-detection algorithm. Twenty-two pts developed 
restenosis at the slanted site (> 50% stenosis). The following angiogrephic 
measurements were performed after slanting and at follow-up: reference 
vessel diameter (RD), elastic recoil (REC), minimal lumen diameter (MLD}, 
and slant diameter (SD, vessel free of contrast). Values are expressed in 
ram" 
After 8tenting Follow.up REC SC IH 
MLD SD MLD SO 
WithoutRE 3.5:E0.4 3,6d:0.42.9:E0.S3.3:E0,4-0.4:E8.2 0,2±0,20.4~0.5 
WithRE 3.3:E0,4" 3,5:E0.4 1,4-~0.73,2~0.3 4.44-8.4* 0.:)~0.1 1.8:1:0,0" 
*p < 0,05 compared to Without RE 
On average, IH was responsible for 7lP/o of the late loss in the w~thout RE 
greup and 97% in the with RE group. We conclude that intimal proliferation is 
the major mechanism off late lumen loss (and cons*quently, restenosis) after 
Palmaz-Schatz slant implantation. Elastic recoil and stent compression play 
a minor role in the renarrowing process (although the former is significantly 
greater in pts with restanosis), 
~ Radiat ion Parameters Assoc iated With Coronary 
Irradiat ion Pilot Study to Inhibit  Restenos is  After 
Slant ing 
Shirish K. Jeni, Vincent Maasuilo, Prabhakar Tripuraneni, Paul S. Teirstein, 
Steve Steuterman, Haoran Jin, Stephanie Degenkolb. Scripps Clinic and 
Research Foundation, La Julia, CA 
Restenosis is a meier problem associated with coronary balloon angioplasty 
as well as slant implantation. Low dose brachy radiotherapy immediately 
after stenting may reduce the restenosis rate. To examine this issue, a pilot 
study has been launched to deliver localized radiation to the stented vessel 
with the use of radioactive Ir-192 sources, Ir-192 decays with a hall life 
of 74 days by emitting 350 keV x-rays, The sources were in the form of 
cylindfloal seeds (0.3 cm x 0.05 cm) and were imbedded in a nylon ribbon 
of _< 0.08 cm in diameter. The ribbon had either 5 or 9 seeds with a spacing 
of 0.1 cm to allow flexibility needed for o'lthetefization. A probing catheter 
(0.135 cm CO) was utilized to guide the radioactive ribbon to the implanted 
Palmaz-Schatz slant(s). A minimum radiation dose of approximately 800 
centiGray (cGy) was delivered to the atheresclerotic lesion while keeping 
the maximum tissue dose at < 3000 cGy. Treatment ime depended upon 
the radioactive strength of the Ir-tg2 seeds and was in the range of 20--40 
minutes. The radiation dose distribution around our ribbon was analyzed by 
using film dasimetry and thermoluminescent dosimeters. Also, we examined 
radiation exposure levels in and around the cethetedzation rooms during the 
radiation procedure. By utilizing portable radiation shields, we were able to 
reduce room radiation levels to well below 2 mR/hr limit set by regulatory 
agencies for non-occupational exposure. Our experience with 30 patients to 
date indicates this is a sate procedure with no eady adverse effects. 
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~ Llpoprotein(a) Concentration Does Not 
Correlate With Angiographic Restenoais 
Francis Ergina, Gilles C8~, Antonio Ciampi, Bruno Farrah, Serge Doucet, 
Luo Biico~au, Jean-Claude Tardif, Raoul eonan, Bela Charles Solymoss. 
Montreal Heart Institute, Montreal, Quebec, Canada 
Background: Although some research groups have reported a good corm- 
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lation betwe,m lipopmtaln(a) (Lp(a)) concentrations and the development of 
restenosis post PTCA, the relationship between Lp(a) and restenosis remains 
controversial. 
Method: To evaluate the predictive value of I-p(a) for restenosis we mea- 
sured Lp(a) concentrations of patients undergoing PTCA and enrolled in 
prospective restenosis trials at the Montreal Heart Institute. Between March 
1991 and September 1992, 134 patients (107 men) had full lipid profiles 
including Lp(e) level measurements. The mean age of our study popcletior, 
was 54.6 4- 8.7, 28% had a previous MI, 25% were smokers, 16% were dia- 
betic and 66% had hyperohott:sterolemia. All patients had follow up coronary 
angiography at 6 months. Sevedty of the lesions after PTCA and at follow-up 
was assessed by quantitative coronary angingraphy. Restenosis was de- 
fined as reocclusion of > 50% of a previous PTCA site. Lp(a) concentrations 
were measured by monoclc~al/polyclonal s ndwich enzyme immunoassay 
performed on fresh serum samples. 
Results: Restsnosis occurred in 47 patients (35%). Mean Lp(a) values for 
the restenosis group was 0.53 -i- 0.56 g/L For the no restenosis group (N = 
86) mean Lp(a) values was 0.57 -4- 0.68 g/I. Univadate and logistic regression 
analysis howed no correlation with any lipids including Lp(a). 
Conclusion: Our data does not support he theory of a correlation between 
serum I.p(a) concentrations and the incidence of restenosis. A prospective 
angiographic trial comp~dng patients with high Lp(a) with that of low levels 
is still required. 
[ 1012-1021 Dual Determination of Anglotensin-Converting 
Enzyme and Angistensln-II "l~pe 1 Receptor 
Genotypes as Predictor of Restenosis After 
Coronary Angioplasty 
Martial Hamon, Carole Amant, Chdstophe Bauters, Florence Richard, 
Nicole Helbecque, Frangois Passard, Eugene Mc Faddan, 
Jean-Marc Lablanche, Michel Bertrand, Philippe AmouyeL CHRU de Lille 
and Institut Pasteur de Lille 
Recebltly, the Insartion/Detetion (I/D) polymorphism of the angiotonsincon- 
vetting enzyme (ACE) gene andtheA/C 11ss polymorphism of the angiotensin- 
II type 1 receptor (AGTr R) gene have been demonstrated to have a.synergis- 
tic effect on the occurence of myocardial infarction. We studied the possible 
influence of these two genetic dsk factors on the occurrence of restenosis in 
271 consecutive patients, who underwent successful single lesion coronary 
angioplssty with systematic angiographic follow-up. The ganotype distribu- 
tions in the whole sample were 34%, 50% and 16% for DD, ID and It, 
respectively, and 11%, 38% and 51% for CC, AC and AA respectively. These 
genotype frequencies were compatible with the Hardy-Weinberg hypothesis. 
The results of quantitative coronary angiography did not show any signiff- 
c~'~t differences in reference diameter and minimal lumen diameter (MLD) of 
stenosis before aogioplasty. Immediately after PTCA, the MLD and the acute 
gain ware similar among groups of genotypes. At follow-up anglography, the 
MLD, the late loss and the net gain were not different according to genotypas. 
Finally, 4 combinations of genotypes ware defined as a dominant effect of the 
ACE D allele and a codominant effect of the AGTr R C allele. No synergistic 
effect ceutd be detected on the occurrence of restenosis. In Conclusion, 
this quantitative study did not reveal any effect of either palymorphism on 
restenosls alone or in o)mbination. 
L~101 2-1 03 1 Circulating Serum Levels of bFGF, VEGF, and 
TGF-bl In Patients Undergoing PTCA 
Man-Hoa tam, Martin Bouchard, R~mi Marfal, Angelica Flesar, 
Guy Leclero. Notre-Dame Hospital, Montr6al, Qu~.bec, Canada 
Growth factor release from damaged cells following injury could be a key 
Initiator of vascular smooth muscle coils proliferation which could eventually 
lead to restsnosis. The purpose of this study was to assess and compare the 
circulating serum levels of basic Rbroblast Growth Factor (bFGF), Vascular 
Endothelial Growth Factor (VEGF), and Transforming Growth Factor-beta 
(TGF-,81) in 25 patients undergoing parcutaneous transluminal coronary an- 
gioplasty (PTCA). Blood samples were prospectively collected immediately 
pie, post, 24, and 48 hours post procedure and growth factor levels were 
assessed immunologically using monoclosal antibodies by ELISA testing. 
A significant increase of bFGF level was observed immediately post-PTCA 
as compared to the level measured pre-pmcedure (15.1 ± f,9 pg/ml vs 9.7 
:E 1.7 pg/ml, P = 0.039). At 24 h and 48 h post-PTCA the level of bFGF 
fell respectively to 3,3 4- 0.5 pg/ml and 2.9 4- 0,5 pg/ml, which represent 
a significant decrease as compared to the level reached immediately post 
angioplasty (P = 0.0001 at beth times). VEGF levels showed significant de- 
crease immediately following the angioplesty (172 ± 31.7 pg/mt (pre) vs 34.9 
2.8 pg/ml (post) P = 0.0001). However, at 24 h post-PTCA, the levels of 
VEGF reached 277 4- 70.9 Wml (P = 0.0013 as compared to post) and 
remained elevated at that level at 48 h (254 ~ 46.3 pg/ml). We observed no 
slgnifl~nt vadatlons in the levels of TGF-/H measured at the different times. 
Conclusions: Cimulating serum levels of both bFGF and VEGF are signifi- 
santiy modified post-PTCA in human, with a rapid but short-lived increase 
with bFGF and a late and sustained increase with VEGR 
[ 10i  2-104 1 Serum Levels o~ C-Reactive Protein Predict 
Acute Complications and Restenosis Alter 
PTCA in Unstable Angina 
Antonino Buffon, Giovanna Uuzzo, Luigi M. Biasucci, Gaetano Quaranta, 
Giuseppina Caiigiud, Francesco Summada, Ritz L. Gdllo, Antonio 
G. Rabuzzi, Filippa Crea, Attilio Mased. Cardiology, Catholic Universi~, 
Rome, Italy 
It is well recognized that in patients (pts) with unstable angina (UP,) coronary 
angioplasty (PTCA) is hampered by an higher rate of acute complications 
and restenosis. The activation of the inflammatory system observed in UA 
may increase the dsk of complications following PTCA, because of the vaso- 
constdctive and pmcoagulant effects of cytokines. To test this hypothesis, we 
measured serum levels of C-reactive protein (a pmtotypic marker of inflam- 
maton, produced by the hepatic ells mainly after intedeukin-6 stimulation) 
in 36 pts with UA, pdor to single-vessel PTCA. Results: Elevated serum 
levels of CRP (> 3 rag/I) were found in 28/36 (78%) pts: median 15.6 mg/1, 
range 3.2-200 mg/I. Ten of the 28 UA pts (36°/=) with high levels of CRP 
had acute complications: 9 pts had o".'.'.'.'.'.'.'.'~J u sic n dudng the procedure (requidng 
stent application in 2 10ts, immediate coronary bypass surgery in 3 pts and 
thmmbelysis in 4 pts); 1 10t developed an acute myocardial infarction within 
24 hours. Furthermore, 12 of the 18 lOtS (67%) with elevated serum levels of 
CRP and no acute complications had recurrence of class IlIB (Braunwaid) 
UA, with angiographic evidence of restenosis, within 6 months. Conversely, 
none of the 8 pts with a normal value of CRP had acute complications 
and only 2 (25%) had restenosis within 6 months, with a stable pattern of 
symptoms (p = 0.015 vs UA pts with elevated levels of CRP), Moreover, a 
multivadato analysis confirmed that serum level of CRP prior to PTCA was a 
strong predictor of acute complications (tO = 0.021) and restenosis (p = 0.018) 
~iter PTCA, independent of clinical, angiographic and procedural variables. 
Conclusions: Our data demonstrate that elevated levels of CRP are pre- 
dictive of high dsk of acute cemptication and raised rate of restenosis with 
an unstable clinical presentation, inpatients with unstable angina submitted 
to PTCA, possibly because of enhanced cytokines production. 
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11013-1161 Compensation for Systolic-Diastolic Variation in 
Intracoronary Ultrasound Image Acquisition 
Mark Appleby, Andrew Deaner, Martin Rothman. Royal London Hospital, 
London E1 1BB 
Measudog intranoronary ultrasound (ICUS) images in systole (S) and diastole 
(D) at the same position in a vessel is necessary in studies of wall motion 
and vessel compliance. Longitudinal ICUS catheter moton dudng the cardiac 
cycle means different sections of vessel are imaged uring S and D, The aim 
of this study was to quantify this motion to enable compensation. 
Methods: 19 patients underwent ICUS imaging using Boston Sciantif'¢ 30 
MHz 3.5 F catheters and a Hewiett Packard Sonos 100 ¢ system following 
coronary stunt insertion. Withdrawals were performed using a microproces- 
sor controlled pull-back dev'ce gated to the R-were and moving 0.1 mm or 
0.2 mm per R-R intentaL Digitized v'~eo-frar~,as were ntagnitied and anal- 
ysed on a Power PC using NIH image ® linked to an EXCEL ® spreadsheet. 
The veesal-stent interfaces were used to allow matching of images. The lon- 
gitudinal distance between matched images were calculated and the impact 
on area measurements assessed. 
Results: 
Mean SD 
Inner Luminal Area (ILA) 7.07 rmn 2 1.82 mm ~ 
Media Bounded Area (MBA 14.3 mm 2 1.53 mm ~" 
Longitudinal separation ofmatching sys-di frames 0.24 mm 2 0.15 mm 2 
ILA sys-dl vafiaticn (same position-- uncompensated) 0.67 mm 2 0.056 mm z
MBA sys-dl variation (same position-- uncompensated) 0.57 mm 2 0.035 m~v ?- 
ILA sys-di variation (compensated) 0.41 mm 2 0.040 mrn 2
MBA Syst-Diasl vadalicn (compensated) 0.37 mm 2 0.031 mm 2 
Sys - Systolic; DI - Diastolic 
Conclusions: Beat to beat tongifudinal catheter motion of 0.1-0.4 mm sig- 
